NovaBridge Biosciences (NBP) Treasury Shares (2017 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Treasury Shares data on file, last reported at -$5.0 million in Q4 2025.

• Quarterly Treasury Shares rose 19.0% year-over-year to -$5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.0 million (up 19.0% YoY) and the FY2025 annual result came in at -$5.0 million, up 19.0% from the prior year.
• Treasury Shares climbed to -$5.0 million in Q4 2025 per NBP's latest filing, from -$5.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.9 million in Q4 2025 and bottomed at $231766.3 in Q4 2021.
• The 4-year median for Treasury Shares is $856224.2 (2022), against an average of $1.2 million.
• The widest annual swing landed in 2023, when Treasury Shares surged 164.06%; it then sank 178.91% in 2024.
• Tracing NBP's Treasury Shares over 4 years: stood at $3.0 million in 2022, then surged by 164.06% to $7.9 million in 2023, then plunged by 178.91% to -$6.2 million in 2024, then increased by 19.0% to -$5.0 million in 2025.
• Per Business Quant, the three latest NBP Treasury Shares figures stand at -$5.0 million (Q4 2025), -$5.2 million (Q3 2025), and -$5.6 million (Q2 2025).

Peer Comparison